Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.

Jensen DM, Brunda M, Elston R, Gane EJ, George J, Glavini K, Hammond JM, Le Pogam S, Nájera I, Passe S, Piekarska A, Rodriguez I, Zeuzem S, Chu T; ANNAPURNA study investigators.

Liver Int. 2016 Apr;36(4):505-14. doi: 10.1111/liv.12997. Epub 2015 Dec 12.

PMID:
26519669
2.

The effect of tendon excursion velocity on longitudinal median nerve displacement: differences between carpal tunnel syndrome patients and controls.

Filius A, Thoreson AR, Wang Y, Passe SM, Zhao C, An KN, Amadio PC.

J Orthop Res. 2015 Apr;33(4):483-7. doi: 10.1002/jor.22804. Epub 2015 Feb 17.

3.

Collagen gel contraction as a measure of fibroblast function in an animal model of subsynovial connective tissue fibrosis.

Yang TH, Thoreson AR, Gingery A, Larson DR, Passe SM, An KN, Zhao C, Amadio PC.

J Orthop Res. 2015 May;33(5):668-74. doi: 10.1002/jor.22835. Epub 2015 Mar 18.

4.

TGF-β signaling regulates fibrotic expression and activity in carpal tunnel syndrome.

Gingery A, Yang TH, Passe SM, An KN, Zhao C, Amadio PC.

J Orthop Res. 2014 Nov;32(11):1444-50. doi: 10.1002/jor.22694. Epub 2014 Jul 30.

5.

Altered median nerve deformation and transverse displacement during wrist movement in patients with carpal tunnel syndrome.

Wang Y, Filius A, Zhao C, Passe SM, Thoreson AR, An KN, Amadio PC.

Acad Radiol. 2014 Apr;21(4):472-80. doi: 10.1016/j.acra.2013.12.012.

6.

Transverse ultrasound assessment of median nerve deformation and displacement in the human carpal tunnel during wrist movements.

Wang Y, Zhao C, Passe SM, Filius A, Thoreson AR, An KN, Amadio PC.

Ultrasound Med Biol. 2014 Jan;40(1):53-61. doi: 10.1016/j.ultrasmedbio.2013.09.009. Epub 2013 Nov 7.

7.

Transforming growth factor-β (TGF-β) expression is increased in the subsynovial connective tissues of patients with idiopathic carpal tunnel syndrome.

Chikenji T, Gingery A, Zhao C, Passe SM, Ozasa Y, Larson D, An KN, Amadio PC.

J Orthop Res. 2014 Jan;32(1):116-22. doi: 10.1002/jor.22485. Epub 2013 Sep 9.

8.

Subsynovial connective tissue is sensitive to surgical interventions in a rabbit model of carpal tunnel syndrome.

Sun YL, Moriya T, Zhao C, Kirk RL, Chikenji T, Passe SM, An KN, Amadio PC.

J Orthop Res. 2012 Apr;30(4):649-54. doi: 10.1002/jor.21565. Epub 2011 Oct 18.

9.

Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19.

Drucker KL, Kitange GJ, Kollmeyer TM, Law ME, Passe S, Rynearson AL, Blair H, Soderberg CL, Morlan BW, Ballman KV, Giannini C, Jenkins RB.

Genes Chromosomes Cancer. 2009 Oct;48(10):854-64. doi: 10.1002/gcc.20688.

10.

MGMT immunohistochemical expression and promoter methylation in human glioblastoma.

Rodriguez FJ, Thibodeau SN, Jenkins RB, Schowalter KV, Caron BL, O'neill BP, James CD, Passe S, Slezak J, Giannini C.

Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):59-65. Erratum in: Appl Immunohistochem Mol Morphol. 2008 May;16(3):307. David James, Charles [corrected to James, Charles David].

PMID:
18091318
11.

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.

Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC.

Cancer Res. 2006 Oct 15;66(20):9852-61.

12.

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K.

Cancer. 2005 Oct 1;104(7):1468-77.

13.

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H, Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD.

Clin Cancer Res. 2005 May 1;11(9):3326-34.

14.

Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.

Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB.

Genes Chromosomes Cancer. 2005 Jan;42(1):68-77.

PMID:
15472895
15.

Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy.

Mauss S, Valenti W, DePamphilis J, Duff F, Cupelli L, Passe S, Solsky J, Torriani FJ, Dieterich D, Larrey D.

AIDS. 2004 Sep 3;18(13):F21-5.

PMID:
15316334
16.

Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors.

Dupont J, Bienvenu B, Aghajanian C, Pezzulli S, Sabbatini P, Vongphrachanh P, Chang C, Perkell C, Ng K, Passe S, Breimer L, Zhi J, DeMario M, Spriggs D, Soignet SL.

J Clin Oncol. 2004 Aug 15;22(16):3366-74.

PMID:
15310782
17.

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group.

N Engl J Med. 2004 Jul 29;351(5):438-50.

18.

Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD.

Cancer Res. 2002 Nov 1;62(21):6205-10.

19.

Primary neuroblastoma of the maxillary sinus.

Wei JL, Scheithauer BW, Smith JS, Jenkins RB, Passe SM, Arndt CA, Strome SE.

Int J Pediatr Otorhinolaryngol. 2002 Apr 25;63(2):155-62.

PMID:
11955607
20.

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.

Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD.

Clin Cancer Res. 2002 Jan;8(1):180-7.

21.

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?

Burger PC, Pearl DK, Aldape K, Yates AJ, Scheithauer BW, Passe SM, Jenkins RB, James CD.

J Neuropathol Exp Neurol. 2001 Nov;60(11):1099-104.

PMID:
11706939
22.

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB.

J Natl Cancer Inst. 2001 Aug 15;93(16):1246-56.

PMID:
11504770
23.

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P; Lenercept Study Group.

Crit Care Med. 2001 Mar;29(3):503-10.

PMID:
11373411
24.

Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.

Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K.

Am J Pathol. 2001 Apr;158(4):1253-62.

25.

Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.

Kim J, Zhi J, Satoh H, Koss-Twardy SG, Passe SM, Patel IH, Pazdur R.

Anticancer Drugs. 1998 Sep;9(8):689-96.

PMID:
9823427
26.

The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Zhi J, Melia AT, Guerciolini R, Koss-Twardy SG, Passe SM, Rakhit A, Sadowski JA.

J Clin Pharmacol. 1996 Jul;36(7):659-66.

PMID:
8844450
27.

The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients.

Massarella JW, Nazareno LA, Passe S, Min B.

Pharm Res. 1996 Mar;13(3):449-52.

PMID:
8692740
28.

The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients.

Nazareno LA, Holazo AA, Limjuco R, Passe S, Twardy SK, Min B, Massarella JW.

Pharm Res. 1995 Oct;12(10):1462-5.

PMID:
8584481
29.

The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers.

Melia AT, Zhi J, Koss-Twardy SG, Min BH, Smith BL, Freundlich NL, Arora S, Passe SM.

J Clin Pharmacol. 1995 Aug;35(8):840-3.

PMID:
8522642
30.

The effects of cimetidine and ranitidine on the pharmacokinetics of cifenline.

Massarella JW, Defeo TM, Liguori J, Passe S, Aogaichi K.

Br J Clin Pharmacol. 1991 Apr;31(4):481-3.

31.

The effect of trimoprostil (trimethyldesoxy prostaglandin E2) on the intrauterine pressure in women.

Reele SB, Nauss-Karol C, Lusaitis AA, Passe SM.

Clin Pharmacol Ther. 1988 Aug;44(2):179-85.

PMID:
3293873
32.

Evaluation of effect of levamisole on feline mammary cancer.

MacEwen EG, Hayes AA, Mooney S, Patnaik AK, Harvey HJ, Passe S, Hardy WD Jr.

J Biol Response Mod. 1984 Oct;3(5):541-6.

PMID:
6502187
33.

Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors.

Castro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerber C, Miller D, Seligmann M, Bernard J.

Cancer. 1984 Aug 15;54(4):675-86.

PMID:
6589029
34.

Prognostic factors for feline mammary tumors.

MacEwen EG, Hayes AA, Harvey HJ, Patnaik AK, Mooney S, Passe S.

J Am Vet Med Assoc. 1984 Jul 15;185(2):201-4.

PMID:
6746390
35.

Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors.

Castro-Malaspina H, Schaison G, Briere J, Passe S, Briere J, Pasquier A, Tanzer J, Jacquillat C, Bernard J.

Cancer. 1983 Aug 15;52(4):721-7.

PMID:
6574807
36.

Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.

Passe S, Miké V, Mertelsmann R, Gee TS, Clarkson BD.

Cancer. 1982 Oct 15;50(8):1462-71.

PMID:
7116285
37.

Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables.

Koziner B, Little C, Passe S, Thaler HT, Sklaroff R, Straus DJ, Lee BJ, Clarkson BD.

Cancer. 1982 Apr 15;49(8):1571-9.

PMID:
7066863
38.

Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.

Young CW, Straus DJ, Myers J, Passe S, Nisce LZ, Lee BJ, Koziner B, Arlin Z, Kempin S, Gee T, Clarkson BD.

Cancer Treat Rep. 1982 Apr;66(4):907-14.

PMID:
7042090
39.

Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.

Mertelsmann R, Drapkin RL, Gee TS, Kempin S, Passe S, Thaler HT, Arlin Z, Dowling M, Dufour P, McKenzie S, To L, Comacho E, Oettgen HF, Burchenal JH, Clarkson B.

Cancer. 1981 Nov 15;48(10):2136-42.

PMID:
6170414
40.

Cyclic combination chemotherapy of canine lymphosarcoma.

MacEwen EG, Brown NO, Patnaik AK, Hayes AA, Passe S.

J Am Vet Med Assoc. 1981 Jun 1;178(11):1178-81. No abstract available.

PMID:
6895078
41.

Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literature.

Straus DJ, Passe S, Koziner B, Lee BJ 3rd, Young CW, Clarkson BD.

Cancer Treat Rep. 1981 Mar-Apr;65(3-4):207-11.

PMID:
7016318
42.

Characterization of B-cell leukemias: a tentative immunomorphological scheme.

Koziner B, Kempin S, Passe S, Gee T, Good RA, Clarkson BD.

Blood. 1980 Nov;56(5):815-23.

43.

A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens.

Haghbin M, Murphy ML, Tan CC, Clarkson BD, Thaler HT, Passe S, Burchenal J.

Cancer. 1980 Jul 15;46(2):241-52.

PMID:
6930321
44.

The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.

Straus DJ, Myers J, Passe S, Young CW, Nisce LZ, Lee BJ, Koziner B, Arlin Z, Kempin S, Gee T, Clarkson BD.

Cancer. 1980 Jul 15;46(2):233-40.

PMID:
6155987
45.

Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.

Schneider RJ, Seibert K, Passe S, Little C, Gee T, Lee BJ 3rd, Miké V, Young CW.

Cancer. 1980 Jul 1;46(1):139-43.

PMID:
6992974
46.

Surgical treatment of single brain metastasis: factors associated with survival.

Galicich JH, Sundaresan N, Arbit E, Passe S.

Cancer. 1980 Jan 15;45(2):381-6.

PMID:
7351019
47.

Effect of short-term levamisole therapy on delayed hypersensitivity.

Hirshaut Y, Pinsky CM, Frydecka I, Wanebo HJ, Passe S, Miké V, Oettgen HF.

Cancer. 1980 Jan 15;45(2):362-6.

PMID:
6985836
48.

Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy.

Phillips EA, Kempin S, Passe S, Miké V, Clarkson B.

Clin Haematol. 1977 Feb;6(1):203-22. Review. No abstract available.

PMID:
334410

Supplemental Content

Support Center